Invesco Ltd. Gilead Sciences, Inc. Transaction History

Invesco Ltd.

$453 Billion
Q1 2024

A detailed history of Invesco Ltd. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 11,279,965 shares of GILD stock, worth $774 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

11,279,965

Previous 11,648,801 3.17%

Holding current value

$774 Million

Previous $944 Million 12.44%

% of portfolio

0.18%

Previous 0.23%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$71.58 - $87.29 $26.4 Million - $32.2 Million	-368,836 Reduced 3.17%	11,279,965 $826 Million
Q4 2023 Feb 12, 2024	BUY	$73.27 - $83.09 $94.2 Million - $107 Million	1,285,442 Added 12.4%	11,648,801 $944 Million
Q3 2023 Nov 13, 2023	SELL	$73.94 - $80.67 $40.4 Million - $44.1 Million	-546,678 Reduced 5.01%	10,363,359 $777 Million
Q2 2023 Aug 11, 2023	BUY	$76.01 - $86.7 $56.2 Million - $64.1 Million	739,576 Added 7.27%	10,910,037 $841 Million
Q1 2023 May 12, 2023	BUY	$77.31 - $88.08 $22.2 Million - $25.3 Million	286,994 Added 2.9%	10,170,461 $844 Million

Q4 2022 Feb 13, 2023	BUY	$62.32 - $89.47 $41.5 Million - $59.6 Million	665,849 Added 7.22%	9,883,467 $848 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $25 Million - $28.6 Million	419,902 Added 4.77%	9,217,618 $569 Million
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $63.1 Million - $71.1 Million	1,093,988 Added 14.2%	8,797,716 $544 Million
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $16 Million - $20 Million	276,005 Added 3.72%	7,703,728 $458 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $29.6 Million - $33.6 Million	455,661 Added 6.54%	7,427,723 $539 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $27 Million - $29.2 Million	399,598 Added 6.08%	6,972,062 $487 Million
Q2 2021 Aug 17, 2021	BUY	$63.47 - $69.35 $49.8 Million - $54.4 Million	784,818 Added 13.56%	6,572,464 $453 Million
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $71.1 Million - $81.1 Million	1,185,350 Added 25.76%	5,787,646 $374 Million
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $19.4 Million - $22.1 Million	341,700 Added 8.02%	4,602,296 $268 Million
Q3 2020 Nov 16, 2020	SELL	$62.1 - $78.08 $132 Million - $166 Million	-2,128,881 Reduced 33.32%	4,260,596 $269 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $125 Million - $145 Million	-1,727,329 Reduced 21.28%	6,389,477 $492 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $193 Million - $248 Million	-3,088,817 Reduced 27.56%	8,116,806 $607 Million
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $727 Million - $799 Million	-11,794,288 Reduced 51.28%	11,205,623 $728 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $1.54 Million - $1.7 Million	24,601 Added 0.11%	22,999,911 $1.46 Billion
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $211 Million - $237 Million	3,418,193 Added 17.48%	22,975,310 $1.55 Billion
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $11.9 Million - $13.4 Million	-191,019 Reduced 0.97%	19,557,117 $1.27 Billion
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $1.2 Billion - $1.56 Billion	19,748,136 New	19,748,136 $1.24 Billion

Others Institutions Holding GILD

# of Institutions

1,884

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $86B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account